Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years

Article Abstract:

There have been a variety of side effects from use of sulphasalazine (SSZ) or auranofin (AUR) over years of testing their effects on treatment of rheumatoid arthritis, but there has not been any case of systemic lupus erythematosus (SLE) connected with the use of these drugs, particularly in the five years of a current study. During that time patients who were taking either AUR or SSZ stopped because of rashes, mouth ulcers, leucopenia (which resolved immediately on stopping drug use). Also, some patients became positive for antinuclear antibodies (ANA) but presence of ANA is common in treatment of rheumatoid arthritis and none withdrew because of the rise in ANA.

Author: Capell, Hilary A., Gordon, Margaret-Mary, Porter, Duncan R.
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 1999
Causes of, Complications and side effects, Sulfasalazine, Antinuclear antibodies, Auranofin

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Shrinking central nervous system in systemic lupus erythematosus

Article Abstract:

A 22-year-old patient suffering is examined due to the weakness in her legs and bladder dysfunction. She is diagnosed with neuropsychiatric manifestations of systemic lupus erythematosus; her entire case study is discussed.

Author: Mok, C.C., Mak, A., Tsui, E.Y.K.
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 2004
United States, Case studies, Central nervous system, Neuropsychiatry

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus

Article Abstract:

The results of the study to examine serum mannose binding lectin concentration before and after immunosuppressive treatment in patients with newly diagnosed systemic lupus erythematosus are presented.

Author: Takahashi, R., Tsutsumi, A., Ohtani, K., Muraki, Y., Goto, D., Matsumoto, I., Wakamiya, N., Sumida, T.
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 2005
Japan, Lectins

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Measurement, Systemic lupus erythematosus, Diagnosis
Similar abstracts:
  • Abstracts: Academic physicians' participation in organized medicine. For our patients, not for profits: a call for action
  • Abstracts: More precision in diagnosing appendicitis. Indications for computed tomography in patients with minor head injury
  • Abstracts: The care programme approach: a patient perspective. Model for integrated mental health care measures up
  • Abstracts: Dietary advice in systemic sclerosis: the dangers of a high fibre diet. Chronic fatigue, arthralgia, and malaise
  • Abstracts: Is the Routine Pelvic Examination Needed With the Advent of Urine-Based Screening for Sexually Transmitted Diseases?
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.